Hasan Burak İşleyen։ Thrombocytopenia and Mortality in Critically Ill Cancer Patients
Hasan Burak İşleyen, Cardiologist, Academic Editor at PLOS ONE, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cardio-Oncology, adding:
“Pleased to share our original research published in Cardio-Oncology: ‘ICU-onset atrial fibrillation surrogate, thrombocytopenia, and short-term outcomes in patients with cancer requiring intensive care.’
Cancer, atrial fibrillation, thrombocytopenia, and critical illness create a particularly complex intersection of thrombotic, bleeding, and mortality risks.
Among 9,640 cancer ICU stays, severe thrombocytopenia identified the subgroup in which the ICU-onset atrial fibrillation surrogate showed the clearest adjusted mortality signal. Because atrial fibrillation and clinical outcomes were identified from structured data rather than adjudicated events, these findings should be interpreted as hypothesis-generating rather than causal.
I am grateful to my co-authors and to Cardio-Oncology for providing a rigorous multidisciplinary forum at the intersection of cardiovascular medicine, oncology, and critical care.”
Title: ICU-onset atrial fibrillation surrogate, thrombocytopenia, and short-term outcomes in patients with cancer requiring intensive care: a retrospective ICU cohort study
Authors: Hasan Burak Isleyen, Sevil Tugrul Yavuz, Sercan Bulut, Fatih Kizkapan, Cevahir Alioglu, Erdem Sunger, Ertugrul Okuyan

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 13:50Louise Maes: CONVINCE Trial Imaging Studies Reveal New Insights Into Carotid Plaque and Vascular Risk
-
Nov 20, 2026, 13:50Lara Kurdi: A Presentation of Triple-Positive Antiphospholipid Syndrome
-
Nov 20, 2026, 13:46Rahul Bohra: Beyond Platelet Counts – The Lived Experience of ITP
-
Nov 20, 2026, 13:34Yohei Hisada: How Well Do Mouse Leukemia Models Reflect Human Disease?
-
Nov 20, 2026, 13:20Ilenia Calcaterra: The Inferior Thyroid Arteries as a Window Into Cardiovascular Risk
-
Nov 20, 2026, 13:03Does Being Fit Protect Against VTE? – RPTH Journal
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion